MedTrace Logo

Retroclavicular Approach to Infraclavicular Block

NCT03472911 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2018-05-03

No results posted yet for this study

Summary

In this study, the primary objective was to estimate the minimum effective volume of bupivacaine 0.5% resulting in successful block in 50% of patients (MEV50) for ultrasound-guided retroclavicular approach to infraclavicular brachial plexus block.

Conditions

  • Bupivacaine

Interventions

OTHER

minimum effective volume

The determination of MEV50 and its 95% confidence interval (CI) was based on the staircase up-and-down method by Dixon and Massey.

Sponsors & Collaborators

  • Antalya Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Ali Sait Kavakli, M.D. · Antalya Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-08
Primary Completion
2018-03-01
Completion
2018-03-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03472911 on ClinicalTrials.gov